Insider Ownership
| Role | Insider | Shares | Value | 30d |
|---|
| CEO | Kewalramani Reshma | 110.3K | $51.96M | - |
| VP | Sachdev Amit | 68.5K | $32.27M | - |
| COO | Arbuckle Stuart A | 63.4K | $29.86M | - |
| CFO | WAGNER CHARLES F JR | 51.7K | $24.35M | - |
| VP | | 47.3K | $22.27M | -9,532 |
Transactions
50 transactions · page 23
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|
| 2020-02-06 | Lee Yuchun | Director | Sale+OE | 1,071 | $238.71 | $255,658.41 | -27.6% | → |
| 2020-02-06 | Tatsis Ourania | SVP, CRO | Sale+OE | 967 | $239.43 | $231,526.89 | -1.4% | → |
| 2020-02-06 | Parini Michael | EVP, CL&AO | Sale+OE | 2,526 | $239.42 | $604,782.67 | -0.9% | → |
| 2020-02-06 | Kewalramani Reshma | EVP and CMO | Sale+OE | 2,074 | $239.44 | $496,599.51 | -1.4% | → |
| 2020-02-06 | ALTSHULER DAVID | EVP, Global Research and CSO | Sale+OE | 2,526 | $239.42 | $604,774.76 | -0.9% | → |
| 2020-02-06 | Arbuckle Stuart A | EVP, Chief Commercial Officer | Sale+OE | 2,787 | $239.42 | $667,252.83 | -0.8% | → |
| 2020-02-06 | Silva Paul M | SVP & Controller | Sale+OE | 466 | $239.32 | $111,523.28 | -0.5% | → |
| 2020-02-05 | Lee Yuchun | Director | Sale+OE | 4,000 | $240.61 | $962,434.33 | -12.5% | → |
| 2020-02-03 | Silva Paul M | SVP & Controller | Sale+OE | 2,099 | $231.03 | $484,938.87 | -2.2% | → |
| 2020-02-03 | Sachdev Amit | EVP, Chief Patient Officer | Sale+OE | 4,097 | $231.11 | $946,845.32 | -2.1% | → |
| 2020-02-03 | ALTSHULER DAVID | EVP, Global Research and CSO | Sale+OE | 4,126 | $231.18 | $953,861.49 | -3.0% | → |
| 2020-02-03 | Arbuckle Stuart A | EVP, Chief Commercial Officer | Sale+OE | 530 | $229.99 | $121,894.70 | -1.5% | → |